Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,675.00p
   
  • Change Today:
    -25.00p
  • 52 Week High: 3,020.00
  • 52 Week Low: 1,366.67
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 5,742
  • Market Cap: £87.52m

Latest Deals

Traded Action Notifier PriceAmountValue
27-Apr-26 Buy Bruce Hiscock 1,679.00p 66 £1,108.14
10-Apr-26 Buy Ian James Nicholson 1,848.00p 1,000 £18,480.00
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85
02-Apr-26 Buy Bruce Hiscock 162.20p 126 £204.37

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85
04-Nov-25 Buy Peter John Harrison 2,220.00p 875 £19,425.00
04-Nov-25 Buy Peter John Harrison 2,220.00p 875 £19,425.00
10-Apr-26 Buy Ian James Nicholson 1,848.00p 1,000 £18,480.00

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 306,172 £5,128,381
Ian James Nicholson 14,500 £242,875
Bruce Hiscock 1,666 £27,906

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £87,429,238
Castlefield Fund Partners Limited 985,000 £16,498,750
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £14,823,750
Gresham House Asset Management Limited 627,782 £10,515,348
Miton Group plc 508,135 £8,511,261
The Diverse Income Trust plc 302,300 £5,063,525
Schroders plc 284,795 £4,770,316
Raymond James Wealth Management Limited 265,453 £4,446,338
Wasatch Advisors, Inc. 265,000 £4,438,750
Premier Miton Group plc 262,812 £4,402,101
Canaccord Genuity Group Inc 259,940 £4,353,995
SANFORD DELAND ASSET MANAGEMENT LTD 254,000 £4,254,500
Adrian Williams 253,372 £4,243,981

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 1,675.00p
Change Today -25.00p
% Change -1.47 %
52 Week High 3,020.00
52 Week Low 1,366.67
Volume 5,742
Shares Issued 5.22m
Market Cap £87.52m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  Interim 2nd Interim
Ex-Div 09-Apr-26 06-Nov-25
Paid 24-Apr-26 21-Nov-25
Amount 70.00p 80.00p

Trades for 27-May-2026

Time Volume / Share Price
16:36 1,000 @ 1,669.00p
15:18 250 @ 1,669.00p
13:47 92 @ 1,650.00p
13:45 300 @ 1,669.00p
13:37 300 @ 1,669.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page